Structure-function of cytochromes p450 and flavin-containing monooxygenases. Implications for drug metabolism

Drug Metabolism and Disposition

Volumn 26, Issue 12, 1998, Pages 1223-1231

  Halpert, James R ^a,f   Domanski, Tammy L ^a   Adali, Orhan ^e   Biagini, Christine P ^e   Cosme, Jose ^b   Dierks, Elizabeth A ^d   Johnson, Eric F ^b   Jones, Jeffrey P ^c   De Montellano, Paul Ortiz ^d   Philpot, Richard M ^e   Sibbesen, Ole ^d   Keith Wyatt, W ^e   Zheng, Zhoupeng ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG METABOLIZING ENZYME; UNSPECIFIC MONOOXYGENASE;

BIOTECHNOLOGY; COMPUTER MODEL; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FLAVINS; HUMANS; MIXED FUNCTION OXYGENASES; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

MAMMALIA;

EID: 0032418816     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Atta-Asafo-Adjei E, Lawton MP and Philpot RM (1993) Cloning, sequencing, distribution and expression of a mammalian flavin-containing monooxygenase from a third gene subfamily. J Biol Chem 268:9681-9689.
2. Benson TJ, McKie JH, Garforth J, Borges A, Fairlamb AH and Douglas KT (1992) Rationally designed selective inhibitors of trypanothione reductase: Phenothiazine and related tricyclics as lead structures. Biochem J 286:9-11.
3. Blum H, Leigh JS, Salerno JC and Ohnishi T (1978) The orientation of bovine adrenal cortex cytochrome P-450 in submitochondrial particle multilayers. Arch Biochem Biophys 187:153-157.
4. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S and Karplus M (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 4:187-217.
5. Chang YT, Stiffelman OB, Vakser IA, Loew GH, Bridges A and Waskell L (1997) Construction of a 3D model of cytochrome P450 2B4. Protein Eng 10:119-129.
6. Chen M, Devreotes PN and Gundersen RE (1994) Serine 113 in the site of receptor-mediated phosphorylation of the Dictyostelium G protein A-subunit A2. J Biol Chem 269:20925-20930.
7. Cramer RD, Patterson DE and Bunce JD (1988) Comparative molecular field analysis (CoMFA):1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967.
8. DC Groot MJ, Vermeulen NPE, Kramer JD, Van Acker FAA and Den Kelder GMDO (1996) A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, p450 102, and P450 108. Chem Res Toxicol 9:1079-1091.
9. De Lemos-Chiarandini C, Frey AB, Sabatini DD and Kreibich G (1987) Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies. J Cell Biol 104:209-219.